---
title: "COUNTOURIOTIS ATHENA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/014edc0f-a4e6-5f5e-95ec-793761adfa91
json: https://whiteintel.dev/api/public/dossier/014edc0f-a4e6-5f5e-95ec-793761adfa91
identifier: sec:0001571469
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# COUNTOURIOTIS ATHENA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001571469`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/014edc0f-a4e6-5f5e-95ec-793761adfa91  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/014edc0f-a4e6-5f5e-95ec-793761adfa91  

## Ownership & control

### Holdings / subsidiaries

- **BIOMARIN PHARMACEUTICAL INC** (director) — https://whiteintel.dev/entity/da243f5f-5fb4-5808-b258-c3726f1bb8cb
- **IOVANCE BIOTHERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/5c6bf824-3fda-53f0-a7ee-990bcc569a68
- **Passage BIO, Inc.** (director) — https://whiteintel.dev/entity/3797b803-565f-56ce-9606-f58967c79f6d
- **TP THERAPEUTICS, INC** (officer) — https://whiteintel.dev/entity/e85db82a-135f-5f25-9c67-c9df9435c2d7
- **TP THERAPEUTICS, INC** (director) — https://whiteintel.dev/entity/e85db82a-135f-5f25-9c67-c9df9435c2d7
- **Cardiff Oncology, Inc.** (director) — https://whiteintel.dev/entity/7be8c84b-5666-5c00-9c5c-85d55e0573d2
- **Adverum Biotechnologies, Inc.** (officer) — https://whiteintel.dev/entity/2e479e2e-9ea8-5cf7-a7a3-5d423cc5e323
- **HALOZYME THERAPEUTICS, INC.** (officer) — https://whiteintel.dev/entity/69cc61fe-9e71-5735-ab26-f3a37dc83892
- **AMBIT BIOSCIENCES CORP** (officer) — https://whiteintel.dev/entity/4c71da9e-6a50-575d-8bed-22590c66e271

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **COUNTOURIOTIS ATHENA**. Human view: https://whiteintel.dev/entity/014edc0f-a4e6-5f5e-95ec-793761adfa91 · Structured JSON: https://whiteintel.dev/api/public/dossier/014edc0f-a4e6-5f5e-95ec-793761adfa91._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._